COMP <GO>
USPH vs PNTG // PIOTROSKI F-SCORE QUALITY
U.S. Physical Therapy Inc. (NYSE) VS. The Pennant Group Inc. (NASDAQ) • 15-METRIC TALLY: USPH 9
— PNTG 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: USPH
LAST: $86.57 (+1.47%) • MKT CAP: $1.29B
piotroski-score
8/9
LAST: $42.48 (+0.76%) • MKT CAP: $1.48B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USPH VS. PNTG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | USPH | PNTG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.50% | 11.00% | +0.50 | USPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.3x | 23.9x | -7.60 | USPH | /valuation <GO> |
| Free Cash Flow Yield | 5.81% | 2.44% | +3.37 | USPH | /fcf-yield <GO> |
| Operating Margin | 11.10% | 5.50% | +5.60 | USPH | /operating-margins <GO> |
| Net Profit Margin | 5.10% | 3.10% | +2.00 | USPH | /net-margins <GO> |
| Revenue Growth (YoY) | 16.30% | 36.30% | -20.00 | PNTG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.12% | 0.00% | +2.12 | USPH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.94 | 2.81 | +0.13 | USPH | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 7/9 | +1.00 | USPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.7 | 57.6 | -2.90 | PNTG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.4x | 42.2x | -14.80 | USPH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.29B | $1.48B | -$191.9M | PNTG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | USPH REV | PNTG REV | USPH GROSS % | PNTG GROSS % | USPH FCF | PNTG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $781.0M | $947.7M | 19.2% | — | $75.1M | $36.3M |
| FY 2024 | $671.3M | $695.2M | 18.5% | — | $74.9M | $30.3M |
| FY 2023 | $604.8M | $544.9M | — | — | $82.0M | $33.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USPH // BETA —
PNTG // BETA —